-
1
-
-
84858304153
-
Global asthma prevalence in adults: Findings from the cross-sectional world health survey
-
To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012;12:204
-
(2012)
BMC Public Health
, vol.12
, pp. 204
-
-
To, T.1
Stanojevic, S.2
Moores, G.3
-
4
-
-
0034113824
-
Asthma: From bronchoconstriction to airways inflammation and remodeling
-
Bousquet J, Jeffery PK, Busse WB, et al. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 1720-1745
-
-
Bousquet, J.1
Jeffery, P.K.2
Busse, W.B.3
-
5
-
-
11144358047
-
Hyperplasia of smooth muscle in mild/moderate asthma without changes in cell size or gene expression
-
Woodruff PG, Dolganov GM, Ferrando RE, et al. Hyperplasia of smooth muscle in mild/moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004;169:1001-6
-
(2004)
Am J Respir Crit Care Med
, vol.169
, pp. 1001-1006
-
-
Woodruff, P.G.1
Dolganov, G.M.2
Ferrando, R.E.3
-
6
-
-
60549087960
-
Incremental direct expenditure of treating asthma in the United States
-
Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma 2009;46:73-80
-
(2009)
J Asthma
, vol.46
, pp. 73-80
-
-
Kamble, S.1
Bharmal, M.2
-
7
-
-
2542465414
-
-
European Lung Foundation European Respiratory Society; Geneva
-
European Lung Foundation. European lung white book. European Respiratory Society; Geneva: 2003
-
(2003)
European Lung White Book
-
-
-
9
-
-
84944495461
-
The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock
-
Brocklehurst WE. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 1960;151:416-35
-
(1960)
J Physiol
, vol.151
, pp. 416-435
-
-
Brocklehurst, W.E.1
-
12
-
-
69349105178
-
The leukotriene E4 puzzle: Finding the missing pieces and revealing the pathobiologic implications
-
quiz 415-6
-
Austen KF, Maekawa A, Kanaoka Y, Boyce JA. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J Allergy Clin Immunol 2009;124:406-14; quiz 415-6
-
(2009)
J Allergy Clin Immunol
, vol.124
, pp. 406-414
-
-
Austen, K.F.1
Maekawa, A.2
Kanaoka, Y.3
Boyce, J.A.4
-
13
-
-
0028694621
-
Release of urinary leukotriene E4 in asthmatic subjects: A review
-
In: Dahlen S-E, Hedqvist P, Samuelsson B, Taylor WA, Fritsch J, editors Raven Press; New York
-
Taylor IK. Release of urinary leukotriene E4 in asthmatic subjects: a review. In: Dahlen S-E, Hedqvist P, Samuelsson B, Taylor WA, Fritsch J, editors. Advances in prostaglandin, thromboxane, and leukotriene research. Raven Press; New York: 1994. p. 167-83
-
(1994)
Advances in Prostaglandin, Thromboxane, and Leukotriene Research
, pp. 167-183
-
-
Taylor, I.K.1
-
14
-
-
0026644731
-
Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics
-
Kumlin M, Dahlén B, Bjorck T, et al. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis 1992;146:96-103
-
(1992)
Am Rev Respir Dis
, vol.146
, pp. 96-103
-
-
Kumlin, M.1
Dahlén, B.2
Bjorck, T.3
-
15
-
-
0032725747
-
Anti-inflammatory mechanisms of leukotriene modulators
-
Diamant Z, Sampson AP. Anti-inflammatory mechanisms of leukotriene modulators. Clin Exp Allergy 1999;29:1449-53
-
(1999)
Clin Exp Allergy
, vol.29
, pp. 1449-1453
-
-
Diamant, Z.1
Sampson, A.P.2
-
16
-
-
0041528459
-
Cysteinyl leukotrienes induce NF-kappaB activation and RANTES production in a murine model of allergic asthma
-
Kawano T, Matsuse H, Kondo Y, et al. Cysteinyl leukotrienes induce NF-kappaB activation and RANTES production in a murine model of allergic asthma. J Allergy Clin Immunol 2003;112:369-74
-
(2003)
J Allergy Clin Immunol
, vol.112
, pp. 369-374
-
-
Kawano, T.1
Matsuse, H.2
Kondo, Y.3
-
18
-
-
0031943061
-
Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma
-
Fukushima C, Shimoda T, Matsuse H, et al. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma. Ann Allergy Asthma Immunol 1998;80:245-50
-
(1998)
Ann Allergy Asthma Immunol
, vol.80
, pp. 245-250
-
-
Fukushima, C.1
Shimoda, T.2
Matsuse, H.3
-
19
-
-
20144378092
-
Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism
-
Fukushima C, Matsuse H, Hishikawa Y, et al. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism. Int Arch Allergy Immunol 2005;136:165-72
-
(2005)
Int Arch Allergy Immunol
, vol.136
, pp. 165-172
-
-
Fukushima, C.1
Matsuse, H.2
Hishikawa, Y.3
-
20
-
-
0037699908
-
Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen specific TNF-alpha production and NF-kappaB nuclear translocation in peripheral blood monocytes from atopic asthmatics
-
Tomari S, Matsuse H, Machida I, et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen specific TNF-alpha production and NF-kappaB nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003;33:795-801
-
(2003)
Clin Exp Allergy
, vol.33
, pp. 795-801
-
-
Tomari, S.1
Matsuse, H.2
Machida, I.3
-
21
-
-
0032496618
-
Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial
-
Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med 1998;158:1213-20
-
(1998)
Arch Intern Med
, vol.158
, pp. 1213-1220
-
-
Reiss, T.F.1
Chervinsky, P.2
Dockhorn, R.J.3
-
22
-
-
33749435086
-
Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast
-
Kraft M, Cairns CB, Ellison MC, et al. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006;130:1726-32
-
(2006)
Chest
, vol.130
, pp. 1726-1732
-
-
Kraft, M.1
Cairns, C.B.2
Ellison, M.C.3
-
23
-
-
0037460848
-
Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: Systematic review of current evidence
-
Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ 2003;326:621
-
(2003)
BMJ
, vol.326
, pp. 621
-
-
Ducharme, F.M.1
-
24
-
-
0037249234
-
Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation
-
discussion S43-8
-
Peters-Golden M, Sampson AP. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation. J Allergy Clin Immunol 2003;111:S37-42; discussion S43-8
-
(2003)
J Allergy Clin Immunol
, vol.111
-
-
Peters-Golden, M.1
Sampson, A.P.2
-
25
-
-
0034857142
-
Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma
-
Tomari S, Shimoda T, Kawano T, et al. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma. Ann Allergy Asthma Immunol 2001;87:156-61
-
(2001)
Ann Allergy Asthma Immunol
, vol.87
, pp. 156-161
-
-
Tomari, S.1
Shimoda, T.2
Kawano, T.3
-
26
-
-
0037338743
-
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
-
Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211-16
-
(2003)
Thorax
, vol.58
, pp. 211-216
-
-
Price, D.B.1
Hernandez, D.2
Magyar, P.3
-
27
-
-
25644440589
-
Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids
-
Tsuchida T, Matsuse H, Machida I, et al. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids. Allergy Asthma Proc 2005;26:287-91
-
(2005)
Allergy Asthma Proc
, vol.26
, pp. 287-291
-
-
Tsuchida, T.1
Matsuse, H.2
Machida, I.3
-
28
-
-
0034538067
-
Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
-
Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000;106:1088-95
-
(2000)
J Allergy Clin Immunol
, vol.106
, pp. 1088-1095
-
-
Nelson, H.S.1
Busse, W.W.2
Kerwin, E.3
-
29
-
-
0034821077
-
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy
-
Fish JE, Israel E, Murray JJ, et al. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest 2001;120:423-30
-
(2001)
Chest
, vol.120
, pp. 423-430
-
-
Fish, J.E.1
Israel, E.2
Murray, J.J.3
-
30
-
-
0037372118
-
The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
-
Ringdal N, Eliraz A, Pruzinec R, et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003;97:234-41
-
(2003)
Respir Med
, vol.97
, pp. 234-241
-
-
Ringdal, N.1
Eliraz, A.2
Pruzinec, R.3
-
31
-
-
3242808287
-
Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: A randomized, double-blind, multicenter study
-
Ilowite J, Webb R, Friedman B, et al. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol 2004;92:641-8
-
(2004)
Ann Allergy Asthma Immunol
, vol.92
, pp. 641-648
-
-
Ilowite, J.1
Webb, R.2
Friedman, B.3
-
32
-
-
79955716906
-
Leukotriene antagonists as first-line or add-on asthma-controller therapy
-
Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011;364:1695-707.
-
(2011)
N Engl J Med
, vol.364
, pp. 1695-1707
-
-
Price, D.1
Musgrave, S.D.2
Shepstone, L.3
-
33
-
-
0038555464
-
Effects of montelukast on surrogate inflammatory markers in corticosteroidtreated patients with asthma
-
Currie GP, Lee DK, Haggart K, et al. Effects of montelukast on surrogate inflammatory markers in corticosteroidtreated patients with asthma. Am J Respir Crit Care Med 2003;167:1232-8
-
(2003)
Am J Respir Crit Care Med
, vol.167
, pp. 1232-1238
-
-
Currie, G.P.1
Lee, D.K.2
Haggart, K.3
-
34
-
-
64249140278
-
Efficacy of add-on montelukast in patients with non-controlled asthma: A Belgian open-label study
-
Korn D, Van den Brande P, Potvin E, et al. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr Med Res Opin 2009;25:489-97
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 489-497
-
-
Korn, D.1
Van Den Brande, P.2
Potvin, E.3
-
35
-
-
56649094467
-
Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists
-
Tomari S, Matsuse H, Hirose H, et al. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists. Respiration 2008;76:398-402
-
(2008)
Respiration
, vol.76
, pp. 398-402
-
-
Tomari, S.1
Matsuse, H.2
Hirose, H.3
-
36
-
-
16244392063
-
Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction
-
Carraro S, Corradi M, Zanconato S, et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005;115:764-70
-
(2005)
J Allergy Clin Immunol
, vol.115
, pp. 764-770
-
-
Carraro, S.1
Corradi, M.2
Zanconato, S.3
-
37
-
-
84876493130
-
Ratio of leukotriene E4 to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction
-
Baek HS, Cho J, Kim JH, et al. Ratio of leukotriene E4 to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction. Allergy Asthma Immunol Res 2013;5:26-33
-
(2013)
Allergy Asthma Immunol Res
, vol.5
, pp. 26-33
-
-
Baek, H.S.1
Cho, J.2
Kim, J.H.3
-
38
-
-
0033982571
-
Oral montelukast compared with inhaled salmeterol to prevent exerciseinduced bronchoconstriction: A randomized, double-blind trial
-
Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exerciseinduced bronchoconstriction: a randomized, double-blind trial. Ann Intern Med 2000;132:97-104
-
(2000)
Ann Intern Med
, vol.132
, pp. 97-104
-
-
Edelman, J.M.1
Turpin, J.A.2
Bronsky, E.A.3
-
39
-
-
0025892285
-
Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects
-
Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9
-
(1991)
Am Rev Respir Dis
, vol.143
, pp. 1025-1029
-
-
Christie, P.E.1
Tagari, P.2
Ford-Hutchinson, A.W.3
-
40
-
-
0036142418
-
Improvement of aspirin-intolerant asthma by montelukast a leukotriene antagonist: A randomized double-blind placebo-controlled trial
-
Dahlén SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002;165:9-14
-
(2002)
Am J Respir Crit Care Med
, vol.165
, pp. 9-14
-
-
Dahlén, S.E.1
Malmstrom, K.2
Nizankowska, E.3
-
41
-
-
0034905786
-
Effects of pranlukast on aspirin-induced bronchoconstriction: Differences in chemical mediators between aspirinintolerant and tolerant asthmatic patients
-
Obase Y, Shimoda T, Tomari S, et al. Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirinintolerant and tolerant asthmatic patients. Ann Allergy Asthma Immunol 2001;87:74-9
-
(2001)
Ann Allergy Asthma Immunol
, vol.87
, pp. 74-79
-
-
Obase, Y.1
Shimoda, T.2
Tomari, S.3
-
42
-
-
0036155106
-
Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirinintolerant asthmatic patients
-
Obase Y, Shimoda T, Tomari SY, et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirinintolerant asthmatic patients. Chest 2002;121:143-50
-
(2002)
Chest
, vol.121
, pp. 143-150
-
-
Obase, Y.1
Shimoda, T.2
Tomari, S.Y.3
-
43
-
-
84873964719
-
Menstrual cycle and respiratory symptoms in a general Nordic-Baltic population
-
Macsali F, Svanes C, Sothern RB, et al. Menstrual cycle and respiratory symptoms in a general Nordic-Baltic population. Am J Respir Crit Care Med 2013;187:366-73
-
(2013)
Am J Respir Crit Care Med
, vol.187
, pp. 366-373
-
-
MacSali, F.1
Svanes, C.2
Sothern, R.B.3
-
44
-
-
34548849742
-
Analysis of perimenstrual asthma based on questionnaire surveys in Japan
-
Suzuki K, Hasegawa T, Sakagami T, et al. Analysis of perimenstrual asthma based on questionnaire surveys in Japan. Allergol Int 2007;56:249-55
-
(2007)
Allergol Int
, vol.56
, pp. 249-255
-
-
Suzuki, K.1
Hasegawa, T.2
Sakagami, T.3
-
45
-
-
84876012788
-
Characteristics of perimenstrual asthma and its relation to asthma severity and control. Data from the Severe Asthma Research Program
-
Rao CK, Moore CG, Bleecker E, et al. Characteristics of perimenstrual asthma and its relation to asthma severity and control. Data from the Severe Asthma Research Program. Chest 2013;143:984-92
-
(2013)
Chest
, vol.143
, pp. 984-992
-
-
Rao, C.K.1
Moore, C.G.2
Bleecker, E.3
-
46
-
-
0032825340
-
Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist
-
Nakasato H, Ohrui T, Sekizawa K, et al. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist. J Allergy Clin Immunol 1999;104:585-8
-
(1999)
J Allergy Clin Immunol
, vol.104
, pp. 585-588
-
-
Nakasato, H.1
Ohrui, T.2
Sekizawa, K.3
-
47
-
-
40949109384
-
Leukotriene receptor antagonists: A good choice in the treatment of premenstrual asthma?
-
Pasaoglu G, Mungan D, Abadoglu O, Misirligil Z. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma? J Asthma 2008;45:95-9
-
(2008)
J Asthma
, vol.45
, pp. 95-99
-
-
Pasaoglu, G.1
Mungan, D.2
Abadoglu, O.3
Misirligil, Z.4
-
48
-
-
84859159409
-
Clinical, physiological and antiinflammatory effect of montelukast in patients with cough variant asthma
-
Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and antiinflammatory effect of montelukast in patients with cough variant asthma. Respiration 2012;83:308-15
-
(2012)
Respiration
, vol.83
, pp. 308-315
-
-
Takemura, M.1
Niimi, A.2
Matsumoto, H.3
-
49
-
-
77958101727
-
Comparable effect of a leukotriene receptor antagonist and long-acting beta-adrenergic agonist in cough variant asthma
-
Tamaoki J, Yokohori N, Tagaya E, et al. Comparable effect of a leukotriene receptor antagonist and long-acting beta-adrenergic agonist in cough variant asthma. Allergy Asthma Proc 2010;31:78-84
-
(2010)
Allergy Asthma Proc
, vol.31
, pp. 78-84
-
-
Tamaoki, J.1
Yokohori, N.2
Tagaya, E.3
-
50
-
-
21844431891
-
Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: A subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy
-
Bousquet J, Gaugris S, Kocevar VS, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin Exp Allergy 2005;35:723-7
-
(2005)
Clin Exp Allergy
, vol.35
, pp. 723-727
-
-
Bousquet, J.1
Gaugris, S.2
Kocevar, V.S.3
-
51
-
-
55249101550
-
Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms
-
Agondi RC, Machado ML, Kalil J, Giavina-Bianchi P. Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms. J Asthma 2008;45:754-7
-
(2008)
J Asthma
, vol.45
, pp. 754-757
-
-
Agondi, R.C.1
MacHado, M.L.2
Kalil, J.3
Giavina-Bianchi, P.4
-
52
-
-
33744461567
-
Effect of montelukast on lung function in asthma patients with allergic rhinitis: Analysis from the COMPACT trial
-
Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006;61:737-42
-
(2006)
Allergy
, vol.61
, pp. 737-742
-
-
Price, D.B.1
Swern, A.2
Tozzi, C.A.3
-
53
-
-
77956378655
-
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision
-
Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76.
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 466-476
-
-
Brozek, J.L.1
Bousquet, J.2
Baena-Cagnani, C.E.3
-
54
-
-
0029912952
-
Oral prednisone therapy in experimental rhinovirus infections
-
Gustafson LM, Proud D, Hendley JO, et al. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009-14
-
(1996)
J Allergy Clin Immunol
, vol.97
, pp. 1009-1014
-
-
Gustafson, L.M.1
Proud, D.2
Hendley, J.O.3
-
55
-
-
84887020404
-
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun Nterminal kinase activation
-
Epub ahead of print
-
Papi A, Contoli M, Adcock IM, et al. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun Nterminal kinase activation. J Allergy Clin Immunol 2013; Epub ahead of print
-
(2013)
J Allergy Clin Immunol
-
-
Papi, A.1
Contoli, M.2
Adcock, I.M.3
-
56
-
-
33750728633
-
Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle
-
Moore PE, Cunningham G, Calder MM, et al. Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle. Am J Respir Cell Mol Biol 2006;35:559-64
-
(2006)
Am J Respir Cell Mol Biol
, vol.35
, pp. 559-564
-
-
Moore, P.E.1
Cunningham, G.2
Calder, M.M.3
-
57
-
-
0032578912
-
Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells
-
Behera AK, Kumar M, Matsuse H, et al. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 1998;251:704-9
-
(1998)
Biochem Biophys Res Commun
, vol.251
, pp. 704-709
-
-
Behera, A.K.1
Kumar, M.2
Matsuse, H.3
-
58
-
-
27544507363
-
Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes
-
Matsuse H, Kondo Y, Saeki S, et al. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int Arch Allergy Immunol 2005;138:267-72
-
(2005)
Int Arch Allergy Immunol
, vol.138
, pp. 267-272
-
-
Matsuse, H.1
Kondo, Y.2
Saeki, S.3
-
59
-
-
84877871499
-
Differential airway inflammatory responses in asthma exacerbations induced by respiratory syncytial virus and influenza virus A
-
Matsuse H, Tsuchida T, Fukahori S, et al. Differential airway inflammatory responses in asthma exacerbations induced by respiratory syncytial virus and influenza virus A. Int Arch Allergy Immunol 2013;161:378-82
-
(2013)
Int Arch Allergy Immunol
, vol.161
, pp. 378-382
-
-
Matsuse, H.1
Tsuchida, T.2
Fukahori, S.3
-
60
-
-
28644446476
-
Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa
-
Zhu J, Qiu YS, Figueroa DJ, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 2005;33:531-40
-
(2005)
Am J Respir Cell Mol Biol
, vol.33
, pp. 531-540
-
-
Zhu, J.1
Qiu, Y.S.2
Figueroa, D.J.3
-
61
-
-
84892688395
-
Regulation of dendritic cell functions against harmful pathogens by a leukotriene receptor antagonist
-
Matsuse H, Hirose H, Fukahori S, et al. Regulation of dendritic cell functions against harmful pathogens by a leukotriene receptor antagonist. Allergy Rhinol 2012;3:e30-4
-
(2012)
Allergy Rhinol
, vol.3
-
-
Matsuse, H.1
Hirose, H.2
Fukahori, S.3
-
62
-
-
84863971651
-
Effects of a short-course of pranlukast in combination with systemic corticosteroid on acute asthma exacerbation induced by upper respiratory tract infection
-
Matsuse H, Fukahori S, Tsuchida T, et al. Effects of a short-course of pranlukast in combination with systemic corticosteroid on acute asthma exacerbation induced by upper respiratory tract infection. J Asthma 2012;49:637-41
-
(2012)
J Asthma
, vol.49
, pp. 637-641
-
-
Matsuse, H.1
Fukahori, S.2
Tsuchida, T.3
-
63
-
-
13544276896
-
Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma
-
Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-22
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 315-322
-
-
Bisgaard, H.1
Zielen, S.2
Garcia-Garcia, M.L.3
-
64
-
-
42749090393
-
Obesity and asthma: Possible mechanisms
-
A review of the interaction between obesity and asthma
-
Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008;121:1087-93. A review of the interaction between obesity and asthma.
-
(2008)
J Allergy Clin Immunol
, vol.121
, pp. 1087-1093
-
-
Shore, S.A.1
-
65
-
-
18844409132
-
Adiponectin, an adipocytederived protein
-
Nedv́dková J, Smitka K, Kopský V, Hainer V. Adiponectin, an adipocytederived protein. Physiol Res 2005;54:133-40
-
(2005)
Physiol Res
, vol.54
, pp. 133-140
-
-
Nedv́dková, J.1
Smitka, K.2
Kopský, V.3
Hainer, V.4
-
66
-
-
78650052167
-
Body mass index is associated with leukotriene inflammation in asthmatics
-
Giouleka P, Papatheodorou G, Lyberopoulos P, et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest 2011;41:30-8
-
(2011)
Eur J Clin Invest
, vol.41
, pp. 30-38
-
-
Giouleka, P.1
Papatheodorou, G.2
Lyberopoulos, P.3
-
67
-
-
33644865225
-
Influence of body mass index on the response to asthma controller agents
-
Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495-503
-
(2006)
Eur Respir J
, vol.27
, pp. 495-503
-
-
Peters-Golden, M.1
Swern, A.2
Bird, S.S.3
-
69
-
-
0031042693
-
Cigarette smoking stimulates cysteinyl leukotriene production in man
-
Fauler J, Frolich JC. Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest 1997;27:43-7
-
(1997)
Eur J Clin Invest
, vol.27
, pp. 43-47
-
-
Fauler, J.1
Frolich, J.C.2
-
70
-
-
34247344095
-
Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma
-
Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-90
-
(2007)
Am J Respir Crit Care Med
, vol.175
, pp. 783-790
-
-
Lazarus, S.C.1
Chinchilli, V.M.2
Rollings, N.J.3
-
71
-
-
84875220579
-
Effect of montelukast for treatment of asthma in cigarette smokers
-
Price D, Popov TA, Bjermer L, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013;131:763-71
-
(2013)
J Allergy Clin Immunol
, vol.131
, pp. 763-771
-
-
Price, D.1
Popov, T.A.2
Bjermer, L.3
-
73
-
-
84862862358
-
Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients
-
Bozek A, Warkocka-Szoltysek B, Filipowska-Gronska A, Jarzab J. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. J Asthma 2012;49:530-4
-
(2012)
J Asthma
, vol.49
, pp. 530-534
-
-
Bozek, A.1
Warkocka-Szoltysek, B.2
Filipowska-Gronska, A.3
Jarzab, J.4
-
74
-
-
58149398605
-
ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma
-
The study demonstrates the gender differences in LT production
-
Pergola C, Dodt G, Rossi A, et al. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci USA 2008;105:19881-6. The study demonstrates the gender differences in LT production.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 19881-19886
-
-
Pergola, C.1
Dodt, G.2
Rossi, A.3
-
75
-
-
44649161234
-
Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast
-
Rabinovitch N, Strand M, Stuhlman K, Gelfand EW. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol 2008;121:1365-71
-
(2008)
J Allergy Clin Immunol
, vol.121
, pp. 1365-1371
-
-
Rabinovitch, N.1
Strand, M.2
Stuhlman, K.3
Gelfand, E.W.4
-
76
-
-
83155173901
-
Appraising the small airways in asthma
-
Johnson JR, Hamid Q. Appraising the small airways in asthma. Curr Opin Pulm Med 2012;18:23-8
-
(2012)
Curr Opin Pulm Med
, vol.18
, pp. 23-28
-
-
Johnson, J.R.1
Hamid, Q.2
-
77
-
-
84864003920
-
Do small airway abnormalities characterize asthma phenotypes? in search of proof
-
Contoli M, Kraft M, Hamid Q, et al. Do small airway abnormalities characterize asthma phenotypes? In search of proof. Clin Exp Allergy 2012;42:1150-60
-
(2012)
Clin Exp Allergy
, vol.42
, pp. 1150-1160
-
-
Contoli, M.1
Kraft, M.2
Hamid, Q.3
-
78
-
-
0031817795
-
Inflammatory cell distribution within and along asthmatic airways
-
Haley KJ, Sunday ME, Wiggs BR, et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998;158:565-72
-
(1998)
Am J Respir Crit Care Med
, vol.158
, pp. 565-572
-
-
Haley, K.J.1
Sunday, M.E.2
Wiggs, B.R.3
-
79
-
-
79959624262
-
Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls
-
Tufvesson E, Nihlberg K, Westergren-Thorsson G. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls. Prostaglandins Leukot Essent Fatty Acids 2011;85:67-73
-
(2011)
Prostaglandins Leukot Essent Fatty Acids
, vol.85
, pp. 67-73
-
-
Tufvesson, E.1
Nihlberg, K.2
Westergren-Thorsson, G.3
-
80
-
-
39749151010
-
Montelukast inhibits inflammatory responses in small airways of the Guinea-pig
-
Harrison S, Gatti R, Baraldo S, et al. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig. Pulm Pharmacol Ther 2008;21:317-23
-
(2008)
Pulm Pharmacol Ther
, vol.21
, pp. 317-323
-
-
Harrison, S.1
Gatti, R.2
Baraldo, S.3
-
81
-
-
84875209004
-
Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma
-
Nakaji H, Petrova G, Matsumoto H, et al. Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma. Ann Allergy Asthma Immunol 2013;110:198-203
-
(2013)
Ann Allergy Asthma Immunol
, vol.110
, pp. 198-203
-
-
Nakaji, H.1
Petrova, G.2
Matsumoto, H.3
-
82
-
-
84857918547
-
Impact of add-on pranlukast in stable asthma; The additive effect on peripheral airway inflammation
-
Yasui H, Fujisawa T, Inui N, et al. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation. Respir Med 2012;106:508-14
-
(2012)
Respir Med
, vol.106
, pp. 508-514
-
-
Yasui, H.1
Fujisawa, T.2
Inui, N.3
-
83
-
-
0026606394
-
Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma
-
Jeffery PK, Godfrey E, Adelroth E, et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992;145:890-9
-
(1992)
Am Rev Respir Dis
, vol.145
, pp. 890-899
-
-
Jeffery, P.K.1
Godfrey, E.2
Adelroth, E.3
-
84
-
-
0028240265
-
Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
-
Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22
-
(1994)
Am J Respir Crit Care Med
, vol.150
, pp. 17-22
-
-
Trigg, C.J.1
Manolitsas, N.D.2
Wang, J.3
-
85
-
-
0032938331
-
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
-
The AMPUL Study Group
-
Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043-51
-
(1999)
Am J Respir Crit Care Med
, vol.159
, pp. 1043-1051
-
-
Sont, J.K.1
Willems, L.N.2
Bel, E.H.3
-
86
-
-
0033777542
-
Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: Influence of inhaled corticosteroids
-
Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-13
-
(2000)
Am J Respir Crit Care Med
, vol.162
, pp. 1308-1313
-
-
Boulet, L.P.1
Turcotte, H.2
Laviolette, M.3
-
87
-
-
0032845858
-
Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
-
Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999;104:356-63
-
(1999)
J Allergy Clin Immunol
, vol.104
, pp. 356-363
-
-
Hoshino, M.1
Takahashi, M.2
Takai, Y.3
-
89
-
-
33748860064
-
Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge
-
Kelly MM, Chakir J, Vethanayagam D, et al. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest 2006;130:741-53
-
(2006)
Chest
, vol.130
, pp. 741-753
-
-
Kelly, M.M.1
Chakir, J.2
Vethanayagam, D.3
-
90
-
-
4444280860
-
Effects of anti-asthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients
-
Saeki S, Matsuse H, Kondo Y, et al. Effects of anti-asthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients. J Allergy Clin Immunol 2004;114:538-44
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 538-544
-
-
Saeki, S.1
Matsuse, H.2
Kondo, Y.3
-
91
-
-
1642443955
-
Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma
-
Machida I, Matsuse H, Kondo Y, et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 2004;172:1833-8
-
(2004)
J Immunol
, vol.172
, pp. 1833-1838
-
-
Machida, I.1
Matsuse, H.2
Kondo, Y.3
-
92
-
-
22744454954
-
Effects of anti-asthmatic agents on mite allergen pulsed murine bone marrow-derived dendritic cells
-
Machida I, Matsuse H, Kondo Y, et al. Effects of anti-asthmatic agents on mite allergen pulsed murine bone marrow-derived dendritic cells. Clin Exp Allergy 2005;35:884-8
-
(2005)
Clin Exp Allergy
, vol.35
, pp. 884-888
-
-
Machida, I.1
Matsuse, H.2
Kondo, Y.3
-
94
-
-
2342525092
-
The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study
-
Obase Y, Shimoda T, Matsuse H, et al. The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study. Respiration 2004;71:225-32
-
(2004)
Respiration
, vol.71
, pp. 225-232
-
-
Obase, Y.1
Shimoda, T.2
Matsuse, H.3
-
96
-
-
75849157844
-
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma
-
Camargo CA Jr, Gurner DM, Smithline HA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125:374-80
-
(2010)
J Allergy Clin Immunol
, vol.125
, pp. 374-380
-
-
Camargo Jr., C.A.1
Gurner, D.M.2
Smithline, H.A.3
-
97
-
-
70249108874
-
Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbuminsensitized guinea-pigs: The potential as a new asthma medication
-
Muraki M, Imbe S, Sato R, et al. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbuminsensitized guinea-pigs: the potential as a new asthma medication. Int Immunopharmacol 2009;9:1337-41
-
(2009)
Int Immunopharmacol
, vol.9
, pp. 1337-1341
-
-
Muraki, M.1
Imbe, S.2
Sato, R.3
-
98
-
-
79958168428
-
Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model
-
Muraki M, Imbe S, Santo H, et al. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Int Arch Allergy Immunol 2011;155(Suppl 1):90-5
-
(2011)
Int Arch Allergy Immunol
, vol.155
, Issue.SUPPL. 1
, pp. 90-95
-
-
Muraki, M.1
Imbe, S.2
Santo, H.3
-
99
-
-
77952313992
-
Leukotriene A4 hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness
-
Rao NL, Riley JP, Banie H, et al. Leukotriene A4 hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2010;181:899-907
-
(2010)
Am J Respir Crit Care Med
, vol.181
, pp. 899-907
-
-
Rao, N.L.1
Riley, J.P.2
Banie, H.3
-
100
-
-
84883522991
-
Antileukotriene agents for the treatment of lung disease
-
A latest and concise summary of anti-LT agents
-
Scott JP, Peters-Golden M. Antileukotriene agents for the treatment of lung disease. Am J Respir Crit Care Med 2013;188:538-44. A latest and concise summary of anti-LT agents.
-
(2013)
Am J Respir Crit Care Med
, vol.188
, pp. 538-44
-
-
Scott, J.P.1
Peters-Golden, M.2
|